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To the Editor:  
n volume 2, No. 3 (2014) of this journal an interesting 
case report, describing a patient with atrial filbrilla-
tion (AF) and Wolff-Parkinson-White syndrome 
(WPW), was published (1). As the respective authors de-
scribed, the patient was a 23-year-old man who had pal-
pitation, on the Electrocardiograph (ECG), which was 
provided, we saw irregular monomorphic wide complex 
tachycardia with a heart rate of about 150 per minute. 
The patient was treated with digoxin and consequently 
developed severe lethargy, weakness, sweating and 
bradycardia. Post treatment ECG showed normal sinus 
rhythm (heart rate about 60) and obvious signs of WPW 
syndrome (short PR interval, initial delta waves and 
wide QRS). Based on post treatment ECG and response 
to procainamide, the authors concluded that administer-
ing digoxin in this patient was wrong and had resulted in 
the patient's symptoms. I would like to share my points 
of view on this case with your respective readers: 
1. Signs suggesting concurrence of AF and WPW on ECG 
are rapid ventricular rate (too rapid for conduction 
through atrioventricular (AV) node; more than 180-200 
in most literature) and wide bizarre polymorphic QRS 
complexes (resulting from either varying fusions of im-
pulses conducted through accessory pathway and AV 
node or existence of multiple APs) (2-5). Based on his 
pretreatment ECG, the patient did not have any of the 
two mentioned criteria (he had monomorphic wide com-
plex irregular tachycardia with a heart rate of about 
150). To this date, no guideline has recommended as-
suming any case of AF with widened QRS as WPW con-
currency. As the patient did not show any signs suggest-
ing WPW, using digoxin was not wrong based on ECG 
findings (despite the fact that if the physician knew 
about his WPW digoxin administration was surely 
wrong). Therefore, it seems that symptoms that devel-
oped post digoxin administration were not related to the 
patient’s rhythm or baseline WPW syndrome. 
2. Based on 2014 AHA/ACC guideline for the manage-
ment of patients with AF, intravenous procainamide or 
ibutilide are drugs of choice in patients with AF and 
WPW. Intravenous amiodarone is contraindicated in AF 
and WPW concurrency, just like adenosine, digoxin, or 
nondihydropyridine calcium channel antagonists (6). 
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